Virilizing Ovarian Tumor of Low Malignant Potential Associated with Antecedent Tamoxifen Use for Breast Cancer
| Autor: | Wolfgang Holzgreve, Athanassios Dellas, Daniel Surbek, Alfonso C. Almendral, Joachim Torhorst, Irene Hoesli |
|---|---|
| Rok vydání: | 1998 |
| Předmět: |
Oncology
medicine.medical_specialty Antineoplastic Agents Hormonal Mammary gland Breast Neoplasms Ovary medicine.disease_cause Epithelium Ovarian tumor Breast cancer Internal medicine medicine Humans skin and connective tissue diseases Ovarian Neoplasms Gynecology business.industry Obstetrics and Gynecology Neoplasms Second Primary Middle Aged Antiestrogen medicine.disease Virilism Tamoxifen medicine.anatomical_structure Virilizing ovarian tumor Androgens Female Carcinogenesis business hormones hormone substitutes and hormone antagonists medicine.drug |
| Zdroj: | Gynecologic Oncology. 68:293-296 |
| ISSN: | 0090-8258 |
| DOI: | 10.1006/gyno.1998.4935 |
| Popis: | A patient is described who was treated with tamoxifen for breast cancer and developed an androgen-producing ovarian tumor of low malignant potential, which itself is a rare condition. Clinically overt virilism was leading to the diagnosis and promptly improved after surgical removal of the tumor. A causal relationship between tamoxifen use and the tumor is discussed on the basis of the known tumor-inducing potential of tamoxifen. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect